Ozone and the lung: A sensitive issue

Molecular Aspects of Medicine

Volumn 21, Issue 1-2, 2000, Pages 1-48

  Mudway, I S ^a   Kelly, F J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

tocopherol; Air pollution; Ascorbic acid; Bronchoalveolar lavage; Glutathione; Individual variability; Inflammation; Lung function; Lung lining fluid; Ozone; Uric acid

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; ASCORBIC ACID; CELL ADHESION MOLECULE; COLLAGEN; CYTOKINE; GLUTATHIONE; ICOSANOID; MAJOR BASIC PROTEIN; MEMBRANE LIPID; OXIDIZING AGENT; OZONE; URIC ACID;

AIR POLLUTION; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; HUMAN; LUNG EDEMA; LUNG FUNCTION; LUNG INJURY; LUNG LAVAGE; LUNG TOXICITY; MOUSE; NONHUMAN; PNEUMONIA; RAT; REVIEW; SENSITIZATION;

ANIMALS; HUMANS; LUNG DISEASES; OZONE;

EID: 0034653410     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(00)00003-0     Document Type: Review

References (205)

1. Ackermann-Liebrich, U., Leuenberger, P., Schwartz, J., et al., 1997. Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Am. J. Respir. Crit. Care Med. 155 (1), 122-129.
2. 3 on young men and women. J. Appl. Physiol. 62(4):1987;1698-1704.
3. AQS, 2000. Air Quality Strategy for England, Scotland, Wales and Northern Ireland, Department of the Environment, Transport and the Regions. HMSO, London.
4. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant and radical caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA. 78(11):1981;6858-6862.
5. Anderson H.R., Ponce de Leon A., Bland J.M., Bower J.S., Strachan D.P. Air pollution and daily mortality in London 1987-92. BMJ. 312:1996;665-669.
6. Anderson H.R., Spix C., Medina S.et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in european 6 cities: results from the APHEA project. Eur. Respir. J. 10:1997;1064-1071.
7. Aris R.M., Christian D., Hearne P.Q., Finkbeiner W.E., Balmes J.R. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am. Rev. Respir. Dis. 148:1993;1363-1372.
8. Atkinson R.W., Anderson H.R., Strachan D.P., Bland J.M., Bremner S.A., Ponce de Leon A. Short-term associations between outdoor air pollution and visits to accident and emergency departments in London for respiratory complaints. Eur. Respir. J. 13:1999;257-265.
9. Balmes, J.R., Aris, R.M., Chen, L.L., Scannell, C., Tager, I.B., Finkbeiner, W., Christian, D., Kelly, T., Hearne, P.Q., Ferrando, R., Welch, B., 1997. Effects of ozone on normal and potentially sensitive human subjects. Part 1: Airway inflammation and responsiveness to ozone in normal and asthmatic subjects. Res. Rep. Health Eff. Inst. (78), 1-37; discussion 81-99.
10. 1 and FVC do not correlate with measures of inflammation. Am. J. Respir. Crit. Care Med. 153(3):1996;904-909.
11. Barr B.C., Hyde D.M., Plopper C.G., Dungworth D.L. Distal airway remodeling in rats chronically exposed to ozone. Am. Rev. Respir. Dis. 137(4):1988;924-938.
12. Bascom R., Bromberg P.A., Costa D.A., Devlin R., Dockery D.W., Frampton M.W., Lambert W., Samet J.M., Speizer F.E., Utell M. Health effects of outdoor air pollution. Am. J. Respir. Crit. Care Med. 153:1996;3-50.
13. Basha M.A., Gross K.B., Gwizdala C.J., Haidar A.H., Popovich J. Bronchoalveolar lavage neutrophilia in asthmatic and healthy volunteers after controlled exposure to ozone and filtered purified air. Chest. 106(6):1994;1757-1765.
14. Bates D.V. Adverse health impacts of air pollution-continuing problems. Scand. J. Work Environ. Health. 21(6):1995;405-411.
15. Becker R.F. Towards the physiological function of uric acid. Free Radic. Biol. Med. 14:1993;615-631.
16. Beckett W.S., McDonnell W.F., Horstman D.H., House D.E. Role of the parasympathetic nervous system in acute lung response to ozone. J. Appl. Physiol. 59(6):1985;1879-1885.
17. Bleavins M.R., Sargent N.E., Dziedzic D. Effects of cyclosporine A on ozone-induced pulmonary lesion formation: pharmacologic elimination of the T-lymphocyte regulatory response. Arch. Environ. Contam. Toxicol. 28(2):1995;240-247.
18. Blomberg A., Mudway I.S., Nordenhall C., Hedenstrom H., Kelly F.J., Frew A.J., Holgate S.T., Sandstrom T. Ozone-induced lung function decrements do not correlate with early airway inflammatory or antioxidant responses. Eur. Respir. J. 13(6):1999;1418-1428.
19. Boorman G.A., Schwartz L.W., Dungworth C.L. Pulmonary effects of prolonged ozone insult in rats: morphometric analysis of central acinus. Lab. Invest. 43:1980;108-115.
20. Broeckaert F., Arsalane K., Hermans C., Bergamaschi E., Brustolin A., Mutti A., Bernard A. Lung epithelial damage at low concentrations of ambient ozone letter. Lancet. 353(9156):1999;900-901.
21. Brunekreef B., Hoek G., Breugelmans O., Leentvaar M. Respiratory effects of low-level photochemical air pollution in amateur cyclists. Am. J. Respir. Crit. Care Med. 150(4):1994;962-966.
22. Buettner, G.R., Jurkiewicz, B.A., 1996. Chemistry and biochemistry of ascorbic acid. In: Cadenas, E., Packer, L., Dekker, M. (Eds.), Handbook of Antioxidants. New York, pp. 91-115.
23. Burton G.W., Ingold K.U. Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain breaking phenolic antioxidants in vitro. J. Am. Chem. Soc. 103:1981;6472-6477.
24. Burton G.W., Joyce A., Ingold K.U. Is vitamin E the only lipid-soluble chain-breaking antioxidant in human plasma and erythrocyte membranes? Arch. Biochem. Biophys. 221:1983;281-290.
25. Cantin A.M., North S.L., Hubbaral R.C., Crystal R.G. Normal alveolar lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:1987;152-157.
26. Castillejos M., Gold D.R., Dockery D., Tosteson T., Baum T., Speizer F.E. Effects of ambient ozone on respiratory function and symptoms in Mexico City school children. Am. Rev. Respir. Dis. 145(2):1992;276-282.
27. Castleman W.L., Tyler W.S., Dungworth D.L. Lesions in respiratory bronchioles and conducting airways of monkeys exposed to ambient levels of ozone. Exp. Mol. Pathol. 26(3):1977;384-400.
28. Challen P.J.R., Hickish D.E., Bedford L. An investigation of some health hazards in an inert-gas tungsten arc welding shop. Br. J. Ind. Med. 15:1958;276-282.
29. Chang L.Y., Huang Y., Stockstill B.L., Graham J.A., Grose E.C., Menache M.G., Miller F.J., Costa D.L., Crapo J.D. Epithelial injury and interstitial fibrosis in the proximal alveolar regions of rats chronically exposed to a simulated pattern of urban ambient ozone. Toxicol. Appl. Pharmacol. 115(2):1992;241-252.
30. Chang, M.M., Wu, R., Plopper, C.G., Hyde, D.M., 1998. IL-8 is one of the major chemokines produced by monkey airway epithelium after ozone-induced injury. Am. J. Physiol. 275 (3 Pt 1), L524-232.
31. Cheek, J.M., McDonald, R.J., Rapalyea, L., Tarkington, B.K., Hyde, D.M., 1995. Neutrophils enhance removal of ozone-injured alveolar epithelial cells in vitro. Am. J. Physiol. 269 (4 Pt 1), L527-535.
32. Cho H.Y., Hotchkiss J.A., Harkema J.R. Inflammatory and epithelial responses during the development of ozone-induced mucous cell metaplasia in the nasal epithelium of rats. Toxicol. Sci. 51(1):1999;135-145.
33. Chow C.K., Plopper C.G., Chiu M., Dungsworth D.L. Dietary vitamin E and pulmonary biochemical and morphological alterations in rats exposed to 0.1 ppm ozone. Environ. Res. 24:1981;315-324.
34. Chow C.K., Plopper C.G., Dungworth D.L. Influence of dietary vitamin E on the lungs of ozone exposed rats. Environ. Res. 20:1979;309-317.
35. Christian D.L., Chen L.L., Scannell C.H., Ferrando R.E., Welch B.S., Balmes J.R. Ozone-induced inflammation is attenuated with multiday exposure. Am. J. Respir. Crit. Care Med. 158(2):1998;532-537.
36. Coffey M.J., Wheeler C.S., Gross K.B., Eschenbacher W.L., Sporn P.H., Peters-Golden M. Increased 5-lipoxygenase metabolism in the lungs of human subjects exposed to ozone. Toxicology. 114(3):1996;187-197.
37. Coleridge J.C., Coleridge H.M., Schelegle E.S., Green J.F. Acute inhalation of ozone stimulates bronchial C-fibers and rapidly adapting receptors in dogs. J. Appl. Physiol. 74(5):1993;2345-2352.
38. COMEAP, 1998. Committee on the Medical Effects of Air Pollutants, Quantification of the Effects of Air Pollution on Health in the United Kingdom. HMSO, London.
39. Cross, C.E., Matchnik, P.A., Kaur, H., Halltwell, B., Ames, B.N., 1991. Effects of ozone on human plasma. FASEB J. 5, A886.
40. Cross C.E., Reznick A.Z., Packer L., Davies L., Suzuchi Y.J., Halliwell B. Oxidative damage to human plasma proteins by ozone. Free Radic. Res. Commun. 15(6):1992;347-352.
41. Devalia, J.L., Bayram, H., Rusznak, C., Calderon, M., Sapsford, R.J., Abdelaziz, M.A., Wang, J., Davies, R.J., 1997. Mechanisms of pollution-induced airway disease: in vitro studies in the upper and lower airways. Allergy 52 (Suppl. 38), 45-51; discussion 57-58.
42. Devlin R.B., McDonnell W.F., Becker S., Madden M.C., McGee M.P., Perez R., Hatch G., House D.E., Koren H.S. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure. Toxicol. Appl. Pharmacol. 138(1):1996;176-185.
43. Devlin, R.B., McKinnon, K.P., Noah, T., Becker, S., Koren, H.S., 1994. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am. J. Physiol. 266 (6 Pt 1), L612-619.
44. Devlin, R.B., Folinsbee, L.J., Biscardi, F., Hatch, G., Becker, S., Madden, M.C., 1997. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhal. Toxicol. 9, 211-235.
45. Dreschler-Parks D.M., Bedi J.F., Horvath S.M. Pulmonary function responses of older men and women to ozone exposure. Exp. Gerontal. 22:1987;91-101.
46. Driscoll K.E., Simpson L., Carter J., Hassenbein D., Leikauf G.D. Ozone inhalation stimulates expression of a neutrophil chemotactic protein, macrophage inflammatory protein 2. Toxicol. Appl. Pharmacol. 119(2):1993;306-309.
47. Duneclift S., Wells U., Widdicombe J. Estimation of thickness of airway surface liquid in ferret trachea in vitro. Am. J. Physiol. 83:1997;761-767.
48. Dungworth D.L., Castleman W.L., Chow C.K., Mellick P.W., Mustafa M.G., Tarkington B., Tyler W.S. Effect of ambient levels of ozone on monkeys. Fed. Proc. 34:1975;1670-1674.
49. Elasyed, N.M., 1989. Mobilization of vitamin E to the lung under oxidative stress. In: Diplock, A.T., Machlin, L.J., Packer, L, Pryor W.A. (Eds.), Vitamin E: Biochemistry and Health Implications. New York Academy of Sciences, New York, pp. 439-440.
50. Folinsbee, L.J., McDonnell, W.F., Horstman, D.H., 1988. Pulmonary function and symptom responses after 6.6-hour exposure to 0.12 ppm ozone with moderate exercise. JAPCA 38 (1), 28-35.
51. Foster W.M., Silver J.A., Groth M.L. Exposure to ozone alters regional function and particle dosimetry in the human lung. J. Appl. Physiol. 75(5):1993;1938-1945.
52. Frampton M.W., Morrow P.E., Torres A., Cox C., Voter K.Z., Utell M.J. Ozone responsiveness in smokers and nonsmokers. Am. J. Respir. Crit. Care Med. 155(1):1997;116-121.
53. Frampton M.W., Pryor W.A., Cueto R., Cox C., Morrow P.E., Utell M.J. Ozone exposure increases aldehydes in epithelial lining fluid in human lung. Am. J. Respir. Crit. Care Med. 159:1999;1134-1137.
54. Freeman B.A., Mudd J.B. Reaction of ozone with sulfhydryls of human erthrocytes. Arch. Biochem. Biophys. 208:1981;212-220.
55. Frei, B., Stocker, R., England, L., Ames, B.N., 1989. Ascorbate, the most effective antioxidant in human blood plasma. In: Emerit, et al. (Eds.), Antioxidants in Therapy and Preventative Medicine. Plenum Press, New York, pp. 155-163.
56. Frischer T., Studnicka M., Gartner C., Tauber E., Horak F., Veiter A., Spengler J., Kuhr J., Urbanek R. Lung function growth and ambient ozone: a three-year population study in school children. Am. J. Respir. Crit. Care Med. 160(2):1999;390-396.
57. Fujinaka L.E., Hyde D.M., Plopper C.G., Tyler W.S., Dungwort D.L., Lollini L.O. Respiratory bronchiolitis following long-term ozone exposure in bonnet monkeys: a morphometric study. Exp. Lung Res. 8(2-3):1985;167-190.
58. Gertner A., Bromberger-Barnea B., Traystman R., Menkes H. Effects of ozone on peripheral lung reactivity. J. Appl. Physiol. 55(3):1983;777-778.
59. Giamalva D.H., Church D.F., Pryor W.A. A comparison of the rates of ozonation of biological antioxidants and oleate and linoleate esters. Biochem. Biophys. Res. Commun. 133:1985;773-779.
60. Goldstein B.D., Buckley R.D., Cardenas E., Balchum O.J. Ozone and vitamin E. Science. 169:1970;605-606.
61. Gordon T., Taylor B.F., Amdur M.O. Ozone inhibition of tissue cholinesterase in guinea-pigs. Arch. Environ. Health. 36:1981;284-288.
62. Grievink L., Jansen S.M., van't Veer P., Brunekreef B. Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements. Occup. Environ. Med. 55(1):1998;13-17.
63. Grievink L., Zijlstra A.G., Ke X., Brunekreef B. Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxidant supplements. Am. J. Epidemiol. 149(4):1999;306-314.
64. Guth D.J., Warren D.L., Last J.A. Comparative sensitivity of measurements of lung damage made by bronchoalveolar lavage after short-term exposure of rats to ozone. Toxicology. 40(2):1986;131-143.
65. Hackney J.D., Linn W.S. Controlled clinical studies of air pollutant exposure: evaluating scientific information in relation to air quality standards. Environ. Health Perspect. 52:1983;187-191.
66. Hackney J.D., Linn W.S., Buckley R.D.et al. Vitamin E supplementation and respiration effects of ozone in humans. J. Toxicol. Environ. Health. 7:1981;383-390.
67. Harder S., Peden D.B., Koren H.S., Devlin R.B. Comparison of nasal lavage techniques for analysis of nasal inflammation. Am. J. Respir. Crit. Care Med. 151:1994;A565.
68. Harkema J.R., Plopper C.G., Hyde D.M., St. George J.A., Wilson D.W., Dungworth D.L. Response of the macaque nasal epithelium to ambient levels of ozone a morphologic and morphometric study of the transitional and respiratory epithelium. Am. J. Pathol. 128(1):1987;29-44.
69. Harwood J.L., Richards R. Lung surfactant. Mol. Aspects Med. 8:1985;423-514.
70. Hatch, G.E., 1992. Comparative biochemistry of airway lining fluid. In: Schlesinger, R.B. (Ed.), Comparative Biology of the Lung. pp. 617-632.
71. Hauser R., Elreedy S., Hoppin J.A., Christiani D.C. Upper airway response in workers exposed to fuel oil ash: nasal lavage analysis. Occup. Environ. Med. 52:1995;353-358.
72. Hazbun M.E., Hamilton R., Holian A., Eschenbacher W.L. Ozone-induced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am. J. Respir. Cell Mol. Biol. 9(5):1993;568-572.
73. Hazucha M.J., Bates D.V., Bromberg P.A. Mechanism of action of ozone on the human lung. J. Appl. Physiol. 67(4):1989;1535-1541.
74. Hazucha M.J. Relationship between ozone exposure and pulmonary function changes. J. Appl. Physiol. 62(4):1987;1671-1680.
75. Hechter H.H., Goldsmith J.R. Air polution and daily mortality. Am. J. Med. Sci. 241:1961;581-588.
76. Higgins I.T.T., D'Arcy J.B., Gibbons D.I., Avol E.L., Gross K.B. Effect of exposures to ambient ozone on ventilatory lung function in children. Am. Rev. Respir. Dis. 141:1990;1136-1146.
77. Hippeli, S., Elstner, E.F., 1991. Oxygen radicals in air pollution. In: Sies, H. (Ed.). Oxidative Stress: Oxidants and Antioxidants. Academic Press, London, pp. 3-56.
78. Ho C.Y., Lee L.Y. Ozone enhances excitabilities of pulmonary C fibers to chemical and mechanical stimuli in anesthetized rats. J. Appl. Physiol. 85:1998;1509-1515.
79. Hoek G., Fischer P., Brunekreef B., Lebret E., Hofschreuder P., Mennen M.G. Acute effects of ambient ozone on pulmonary function of children in the Netherlands. Am. Rev. Respir. Dis. 147:1993;111-117.
80. Holtzman M.J., Cunningham J.H., Sheller J.R., Irsigler G.B., Nadel J.A., Boushey H.A. Effect of ozone on bronchial reactivity in atopic and nonatopic subjects. Am. Rev. Respir. Dis. 120(5):1979;1059-1067.
81. Holz O., Jorres R.A., Timm P., Mucke M., Richter K., Koschyk S., Magnussen H. Ozone-induced airway inflammatory changes differ between individuals and are reproducible. Am. J. Respir. Crit. Care Med. 159(3):1999;776-784.
82. Horstman D.H., Folinsbee L.J., Ives P.J., Abdul-Salaam S., McDonnell W.F. Ozone concentration and pulmonary response relationships for 6.6-hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am. Rev. Respir. Dis. 142(5):1990;1158-1163.
83. Horvath S.M., Gliner J.A., Folinsbee L.J. Adaptation to ozone: duration of effect. Am. Rev. Respir. Dis. 123(5):1981;496-499.
84. Housley D.G., Eccles R., Richards R.J. Gender difference in the concentration of the antioxidant uric acid in human nasal lavage. Acta Otolaryngol (Stockh). 116:1996;751-754.
85. Housley D.G., Mudway I., Kelly F.J., Eccles R., Richards R.J. Depletion of urate in human nasal lavage following in vitro ozone exposure. Int. J. Biochem. Cell Biol. 27:1995;1153-1159.
86. Hyde D.M., Hubbard W.C., Wong V., Wu R., Pinkerton K., Plopper C.G. Ozone-induced acute tracheobronchial epithelial injury: relationship to granulocyte emigration in the lung. Am. J. Respir. Cell Mol. Biol. 6(5):1992;481-497.
87. Hyde, D.M., Miller, L.A., McDonald, R.J., Stovall, M.Y., Wong, V., Pinkerton, K.E., Wegner, C.D., Rothlein, R., Plopper, C.G., 1999. Neutrophils enhance clearance of necrotic epithelial cells in ozone-induced lung injury in rhesus monkeys. Am. J. Physiol. 277 (6 Pt 1), L1190-1198.
88. Jenkinson S.G., Black R.D., Lawrence R.A. Glutathione concentrations in rat lung bronchoalveolar lavage fluid: effect of hyperoxia. J. Lab. Clin. Med. 112:1988;345-351.
89. Johnson D.A. Ozone inactivation of human α-proteinase inhibitor. Am. Rev. Respir. Dis. 121:1980;1031-1038.
90. Jorres R., Nowak D., Magnussen H. The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am. J. Respir. Crit. Care Med. 153(1):1996;56-64.
91. Kanofsky J.D., Sima P. Singlet oxygen production from the reactions of ozone with biological molecules. J. Biol. Chem. 266:1991;9039-9044.
92. Keefe M.J., Bennett W.D., DeWitt P., Seal E., Strong A.A., Gerrity T.R. The effect of ozone exposure on the dispersion of inhaled aerosol boluses in healthy human subjects. Am. Rev. Respir. Dis. 144(1):1991;23-30.
93. Kehrl H.R., Hazucha M.J., Solic J.J., Bromberg P.A. Responses of subjects with chronic obstructive pulmonary disease after exposures to 0.3 ppm ozone. Am. Rev. Respir. Dis. 131(5):1985;719-724.
94. Kehrl H.R., Peden D.B., Ball B., Folinsbee L.J., Horstman D. Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone. J. Allergy Clin. Immunol. 104(6):1999;1198-1204.
95. Kehrl H.R., Vincent L.M., Kowalsky R.J., Horstman D.H., O'Neil J.J., McCartney W.H., Bromberg P.A. Ozone exposure increases respiratory epithelial permeability in humans. Am. Rev. Respir. Dis. 135(5):1987;1124-1128.
96. Kelly F.J., Birch S. Ozone inhibits cardiac protein synthesis in the mouse. Free Radic. Biol. Med. 14:1993;443-446.
97. Kelly F.J., Blomberg A., Frew A.J., Holgate S.T., Sandstrom T. Antioxidant kinetics in lung lining fluid following exposure of human to nitrogen dioxide. Am. J. Respir. Crit. Care Med. 154:1996;1700-1705.
98. Kelly F.J., Buhl R., Sandström T. Measurement of antioxidants, oxidants and oxidant products in bronchoalveolar lavage fluid. Eur. Respir. Rev. 9(66):1999a;93-98.
99. Kelly F.J., Mudway I.S., Blomberg A., Frew A.J., Sandstrom T. Altered lung antioxidant status in pateints with mild asthma. Lancet. 354:1999b;482-483.
100. Kelly F.J., Mudway I.S., Krishna M.T., Holgate S.T. The free radical basis of air pollution: focus on ozone. Respir. Med. 89:1995;647-656.
101. Kerr H.D., Kulle T.J., McIlhany M.L., Swidersky P. Effects of ozone on pulmonary function in normal subjects: an environmental-chamber study. Am. Rev. Respir. Dis. 111(6):1975;763-773.
102. Kinney P.L., Nilsen D.M., Lippmann M., Brescia M., Gordon T., McGovern T., El-Fawal H., Devlin R.B., Rom W.N. Biomarkers of lung inflammation in recreational joggers exposed to ozone. Am. J. Respir. Crit. Care Med. 154(5):1996;1430-1435.
103. Kinney P.L., Ozkaryak H. Associations of daily mortality and air pollution in Los Angeles county. Environ. Res. 54:1991;99-120.
104. Kleeberger, S.R., Longphre, M., Tankersley, C.G., 1999. Mechanisms of response to ozone exposure: the role of mast cells in mice. Res. Rep. Health. Eff. Inst. (85), 1-30; discussion 31-36.
105. Kleinfield M., Giel C., Tabershaw I.R. Health hazards associated with inert gas shield metal arc welding. Arch. Ind. Health. 15:1957;27-31.
106. Koenig J.Q., Covert D.S., Marshall S.G., Van Belle G., Pierson W.E. The effects of ozone and nitrogen dioxide on pulmonary function in healthy and in asthmatic adolescents. Am. Rev. Respir. Dis. 136(5):1987;1152-1157.
107. Koenig J.Q., Covert D.S., Morgan M.S., Horike M., Horike N., Marshall S.G., Pierson W.E. Acute effects of 0.12 ppm ozone or 0.12 ppm nitrogen dioxide on pulmonary function in healthy and asthmatic adolescents. Am. Rev. Respir. Dis. 132(3):1985;648-651.
108. Koren, H.S., Devlin, R.B., Becker, S., Perez, R., McDonnell, W.F., 1991. Time-dependent changes of markers associated with inflammation in the lungs of humans exposed to ambient levels of ozone. Toxicol. Pathol. 19 (4 Pt 1), 406-411.
109. Krishna M.T., Blomberg A., Biscione G.L., Kelly F., Sandstrom T., Frew A., Holgate S. Short-term ozone exposure upregulates p-selectin in normal human airways. Am. J. Respir. Crit. Care Med. 155(5):1997;1798-1803.
110. Krishna M.T., Madden J., Teran L.M., Biscione G.L., Lau L.C., Withers N.J., Sandstrom T., Mudway I., Kelly F.J., Wall A., Frew A.J., Holgate S.T. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur. Respir. J. 11(6):1998;1294-1300.
111. Kunzli N., Lurmann F., Segal M., Ngo L., Balmes J., Tager I.B. Association between lifetime ambient ozone exposure and pulmonary function in college freshmen - results of a pilot study. Environ. Res. 72(1):1997;8-23.
112. Langford S.D., Bidani A., Postlethwait E.M. Ozone-reactive absorption by pulmonary epithelial lining fluid constituents. Toxicol. Appl. Pharmacol. 132:1995;122-130.
113. Lauritzen S.K., Adams W.C. Ozone inhalation effects consequent to continuous exercise in females: comparison to males. J. Appl. Physiol. 59(5):1985;1601-1606.
114. Leikauf, G.G., Simpson, L.G., Santrock, J., Zhao, Q., Abbinante-Nissen, J., Zhou, S., Driscoll, K.E., 1995. Airway epithelial cell responses to ozone injury. Environ. Health Perspect. 103 (Suppl. 2), 1-5.
115. Li, Z., Daniel, E.E., Lane, C.G., Arnaout, M.A., O'Byrne, P.M., 1992. Effect of an anti-Mo1 MAb on ozone-induced airway inflammation and airway hyperresponsiveness in dogs. Am. J. Physiol. 263 (6 Pt 1), L723-726.
116. Linn W.S., Buckley R.D., Spier C.E., Blessey R.L., Jones M.P., Fischer D.A., Hackney J.D. Health effects of ozone exposure in asthmatics. Am. Rev. Respir. Dis. 117(5):1978;835-843.
117. Longphre M., Zhang L., Harkema J.R., Kleeberger S.R. Ozone-induced pulmonary inflammation and epithelial proliferation are partially mediated by PAF. J. Appl. Physiol. 86(1):1999;341-349.
118. Madden M.C., Eling T.E., Friedman M. Ozone inhibits endothelial cell cyclooxigenase activity through formation of hydrogen peroxide. Prostaglandin. 34:1987;445-463.
119. McCay P.B. Vitamin E: interactions with free radicals and ascorbate. Ann. Rev. Nutr. 5:1985;323-340.
120. McDonnell W.F., Horstman D.H., Abdul-Salaam S., House D.E. Reproducibility of individual responses to ozone exposure. Am. Rev. Respir. Dis. 131(1):1985;36-40.
121. McDonnell W.F., Horstman D.H., Hazucha M.J., Seal E. Jr., Haak E.D., Salaam S.A., House D.E. Pulmonary effects of ozone exposure during exercise: dose-response characteristics. J. Appl. Physiol. 54(5):1983;1345-1352.
122. McDonnell, W.F., Stewart, P.W., Andreoni, S., Seal, E. Jr., Kehrl, H.R., Horstman, D.H., Folinsbee, L.J., Smith, M.V., 1997. Prediction of ozone-induced FEV1 changes. Effects of concentration duration and ventilation. Am. J. Respir. Crit. Care Med. 156 (3 Pt 1), 715-722.
123. McDonnell W.F., Stewart P.W., Smith M.V., Pan W.K., Pan J. Ozone-induced respiratory symptoms: exposure-response models and association with lung function. Eur. Respir. J. 14(4):1999;845-853.
124. McKinnon K.P., Madden M.C., Noah T.L., Devlin R.B. In vitro ozone exposure increases release of arachidonic acid products from a human bronchial epithelial cell line. Toxicol. Appl. Pharmacol. 118(2):1993;215-223.
125. Messineo T.D., Adams W.C. Ozone inhalation effects in females varying widely in lung size: comparison with males. J. Appl. Physiol. 69(1):1990;96-103.
126. Miller, F.J., Overton, J.H. Jr., Jaskot, R.H., Menzel, D.B., 1985. A model of the regional uptake of gaseous pollutants in the lung. I. The sensitivity of the uptake of ozone in the human lung to lower respiratory tract secretions and exercise. Toxicol. Appl. Pharmacol. 79, 11-27.
127. Mills C.A. Respiratory and cardiac deaths in LA smogs during 1956, 1957 and 1958. Am. J. Med. Sci. 239:1960;307-315.
128. Moore G.S., Calabrese E.J.et al. The C57L/J mouse strain as a model for extrapulomonary effects of ozone exposure. Bull. Environ. Contam. Toxicol. 25:1980;578-585.
129. Morgan D.L., Dorsey A.F., Menzel D.B. Erythrocytes from ozone exposed mice exhibit decreased deformality. Fundam. Appl. Toxicol. 5:1985;137-143.
130. Mudway I., Blomberg A., Frew A.J., Holgate S.T., Sandstrom T., Kelly F.J. Antioxidant consumption and repletion kinetics in nasal lavage fluid following exposure of healthy human volunteers to ozone. Eur. Respir. J. 13:1999a;1429-1438.
131. 3-induced inflammation. Am. J. Respir. Crit. Care Med. 157(3):1998;A697.
132. Mudway I., Kelly F.J. Modelling the interactions of ozone with pulmonary epithelial lining fluid antioxidants. Toxicol. Appl. Pharmacol. 148:1998;91-100.
133. 3. Eur. Respir. J. 9:1996;415S.
134. Mudway I.S., Krishna M.T., Frew A.J., MacLeod D., Sandstrom T., Holgate S.T., Kelly F.J. Compromised concentrations of ascorbate in fluid lining the respiratory tract in human subjects after exposure to ozone. Occup. Environ. Med. 56(7):1999b;473-481.
135. Mustafa M.G. Biochemical basis of ozone toxicity. Free Radic. Biol. Med. 9:1990;245-265.
136. Mustafa M.G., Elsayed N.M., Quinn C.L., Postlethwait E.M., Gardner D.E., Graham J.A. Comparison of pulmonary biochemical effects of low-level ozone exposure on mice and rats. J. Toxicol. Environ. Health. 9(5-6):1982;857-865.
137. Mustafa M.G., Cross C.E. Effect of short term ozone exposure on lung mitochondrial oxidative and energy metabolism. Arch. Biochem. Biophys. 162:1974;585-594.
138. Nakamura H., Takada S.D., Smimabuka R., Matsuo T., Obara H. Effect of vitamin E on the response of lung antioxidant enzymes in young rats exposed to hyperoxia. Kobe J. Med. Sci. 33:1987;53-63.
139. Niki, E., Takahashi, M., Komuro, E., 1986. Antioxidant activity of vitamin E in liposomal membranes. Chem. Lett. 1573-1576.
140. Noviski N., Brewer J.P., Skornik W.A., Galli S.J., Drazen J.M., Martin T.R. Mast cell activation is not required for induction of airway hyperresponsiveness by ozone in mice. J. Appl. Physiol. 86(1):1999;202-210.
141. O'Byrne P.M., Walters E.H., Aizawa H., Fabbri L.M., Holtzman M.J., Nadel J.A. Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. Am. Rev. Respir. Dis. 130(2):1984a;220-224.
142. O'Byrne P.M., Walters E.H., Gold B.D., Aizawa H.A., Fabbri L.M., Alpert S.E., Nadel J.A., Holtzman M.J. Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. Am. Rev. Respir. Dis. 130(2):1984b;214-219.
143. Pacht E.R., Davis W.B. Role of transferrin and ceruloplasmin in antioxidant activity of lung epithelial lining fluid. J. Appl. Physiol. 64(5):1988;2092-2099.
144. Pacht R., Kaseki H., Mohammed J.R., Cornwell D.G., Davis W.B. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. J. Clin. Invest. 77:1986;789-796.
145. Passannante A.N., Hazucha M.J., Bromberg P.A., Seal E., Folinsbee L., Koch G. Nociceptive mechanisms modulate ozone-induced human lung function decrements. J. Appl. Physiol. 85(5):1998;1863-1870.
146. Peden D.B., Brown M.E., Wade Y., Rapheal G.D., Berkebile C., Kaliner M.A. Human nasal glandular secretion of a novel antioxidant activity: cholinergic control. Am. Rev. Respir. Dis. 143:1990;545-552.
147. Peden D.B., Setzer R.W. Jr., Devlin R.B. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am. J. Respir. Crit. Care Med. 151(5):1995;1336-1345.
148. Peden D.N., Swiersz M., Ohkubo K.et al. Nasal secretion of the ozone scavenger uric acid. Am. Rev. Respir. Dis. 148:1993;455-461.
149. Pinkerton K.E., Dodge D.E., Cederdahl-Demmler J., Wong V.J., Peake J., Haselton C.J., Mellick P.W., Singh G., Plopper C.G. Differentiated bronchiolar epithelium in alveolar ducts of rats exposed to ozone for 20 months. Am. J. Pathol. 142(3):1993;947-956.
150. Plopper C.G., Duan X., Buckpitt A.R., Pinkerton K.E. Dose-dependent tolerance to ozone: IV. Site-specific elevation in antioxidant enzymes in the lungs of rats exposed for 90 days or 20 months. Toxicol. Appl. Pharmacol. 127(1):1994;124-131.
151. Plopper C.G., Hatch G.E., Wong V., Duan X., Weir A.J., Tarkington B.K., Devlin R.B., Becker S., Buckpitt A.R. Relationship of inhaled ozone concentration to acute tracheobronchial epithelial injury, site-specific ozone dose, and glutathione depletion in rhesus monkeys. Am. J. Respir. Cell Mol. Biol. 19(3):1998;387-399.
152. Ponce de Leon, A., Anderson, H.R., Bland, J.M., Strachan, D.P., Bower, J.S., 1999. Effects of air polution on daily hospital admisions for respiratory disease in London between 1987-88 and 1991-92. J. Epidemiol. Community Health 50 (Suppl. 1), s63-70.
153. Postlethwait E.M., Joad J.P., Hyde D.M., Schelegle E.S., Bric J.M., Weir A.J., Putney L.F., Wong V.J., Velsor L.W., Plopper C.G. Three-dimensional mapping of ozone-induced acute cytotoxicity in tracheobronchial airways of isolated perfused rat lung. Am. J. Respir. Cell Mol. Biol. 22(2):2000;191-199.
154. Powell C.V., Nash A.A., Powers H.J., Primhak R.A. Antioxidant status in asthma. Pediatr. Pulmonol. 18:1994;3-38.
155. Pryor W.A. Can vitamin E protect humans against the pathological effects of ozone in smog. Am. J. Clin. Nutr. 53:1991;702-722.
156. Pryor W.A. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic. Biol. Med. 12:1992;83-88.
157. Pryor W.A. Ozone in all its reactive splendor. J. Lab. Clin. Med. 122(5):1993;483-486.
158. Pryor W.A. Mechanisms of radical formation from reactions of ozone and target molecules in the lung. Free Radic. Biol. Med. 17:1994;451-465.
159. Pryor W.A., Stanley J.P., Blair E., Cullen G.B. Autoxidation of poluyunsaturated fatty acids: Part 1. Effect of ozone on the autoxidation of neat methyl linoleate and methyl linoleate. Arch. Environ. Health. 31:1976;201-210.
160. Pryor W.A., Uppa R.M. A kinetic model for the competative reactions of ozone with amino acid residues in proteins in reverse micelles. J. Biol. Chem. 268(5):1984;3120-3126.
161. Quinton P.M. Composition and control of secretions from tracheal bronchial submucosal glands. Nature. 279:1979;551-552.
162. Raizenne M., Neas L.M., Damokosh A.I., Dockery D.W., Spengler J.D., Koutrakis P., Ware J.H., Speizer F.E. Health effects of acid aerosols on North American children: pulmonary function. Environ. Health Perspect. 104(5):1996;506-514.
163. Reinhart P.G., Gupta S.K., Bhalla D.K. Attenuation of ozone-induced lung injury by interleukin-10. Toxicol. Lett. 110(1-2):1999;35-42.
164. Reynolds H.Y., Newball H.H. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J. Lab. Clin. Med. 84:1974;559-573.
165. Robertson, B., Van Golde, M.G., Batenberg, J.J., 1984. Pulmonary Surfactant. Elsevier, Amsterdam, pp. 1-582.
166. Romieu I., Meneses F., Ramirez M., Ruiz S., Padilla R., Sienra J.J., Gerber M., Grievink L., Dekker R., Walda I., Brunekreef B. Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am. J. Respir. Crit. Care Med. 158(1):1998;226-232.
167. Roux E., Hyvelin J.M., Savineau J.P., Marthan R. Human isolated airway contraction: interaction between air pollutants and passive sensitization. Am. J. Respir. Crit. Care Med. 160(2):1999;439-445.
168. Rustow B., Haupt R., Stevens P.A., Kinze D. Type II pneumocytes secrete vitamin E together with surfactant lipids. Am. J. Physiol. 265:1993;L133-L139.
169. Salvi S., Blomberg A., Rudell B., Kelly F., Sandstrom T., Holgate S.T., Frew A. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am. J. Respir. Crit. Care Med. 159(3):1999;702-709.
170. Samet J.M., Noah T.L., Devlin R.B., Yankaskas J.R., McKinnon K., Dailey L.A., Friedman M. Effect of ozone on platelet-activating factor production in phorbol-differentiated HL60 cells, a human bronchial epithelial cell line (BEAS S6), and primary human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 7(5):1992;514-522.
171. Schelegle E.S., Adams W.C., Siefkin A.D. Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects. Am. Rev. Respir. Dis. 136(6):1987;1350-1354.
172. Schelegle E.S., Carl M.L., Coleridge H.M., Coleridge J.C., Green J.F. Contribution of vagal afferents to respiratory reflexes evoked by acute inhalation of ozone in dogs. J. Appl. Physiol. 74(5):1993;2338-2344.
173. Schelegle E.S., Siefkin A.D., McDonald R.J. Time course of ozone-induced
174. Schultheis A.H., Bassett D.J., Fryer A.D. Ozone-induced airway hyper-responsiveness and loss of neuronal M2 muscarinic receptor function. J. Appl. Physiol. 76(3):1994;1088-1097.
175. Seal E. Jr., McDonnell W.F., House D.E. Effects of age, socioeconomic status, and menstrual cycle on pulmonary response to ozone. Arch. Environ. Health. 51(2):1996;132-137.
176. Seal E. Jr., McDonnell W.F., House D.E., Salaam S.A., Dewitt P.J., Butler S.O., Green J., Raggio L. The pulmonary response of white and black adults to six concentrations of ozone. Am. Rev. Respir. Dis. 147(4):1993;804-810.
177. 3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J. Appl. Physiol. 60(4):1986;1321-1326.
178. Shariff R., Hoshino E.et al. Vitamin E supplementation in smokers. Am. J. Clin. Nutr. 47:1988;758.
179. Shephard R.J., Urch B., Silverman F., Corey P.N. Interaction of ozone and cigarette smoke exposure. Environ. Res. 31(1):1983;125-137.
180. Sherwin, R.P., Richters, V., 1991. Centriacinar (CAR) disease in the lungs of young adults: a preliminary report. In: Berglund, R.L., Lawson, D.R., McKee, D.J. (Eds.), Tropospheric Ozone and the Environment (TR-19). Air and Waste Management Association, Pittsburgh, pp. 178-196.
181. Silverman F., Folinsbee L.J., Barnard J., Shephard R.J. Pulmonary function changes in ozone-interaction of concentration and ventilation. J. Appl. Physiol. 41(6):1976;859-864.
182. Skoza L., Snyder A., Kikkawa Y. Ascorbic acid in bronchoalveolar wash. Lung. 161:1983;99-109.
183. Slade R., Crissman K., Norwood J., Hatch G.E. Comparison of antioxidant substances in bronchoalveolar lavage cells and fluid from humans, guinea pigs, and rats. Exp. Lung Res. 19:1993;469-484.
184. Solic J.J., Hazucha M.J., Bromberg P.A. The acute effects of 0.2 ppm ozone in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 125(6):1982;664-669.
185. Spektor D.M., Lippmann M., Thurston G.D., Lioy P.J., Stecko J., O'Connor G., Garshick E., Speizer F.E., Hayes C. Effects of ambient ozone on respiratory function in healthy adults exercising outdoors. Am. Rev. Respir. Dis. 138(4):1988;821-828.
186. Spektor D.M., Thurston G.D., Mao J., He D., Hayes C., Lippmann M. Effects of single- and multiday ozone exposures on respiratory function in active normal children. Environ. Res. 55(2):1991;107-122.
187. Stern B.R., Raizenne M.E., Burnett R.T., Jones L., Kearney J., Franklin C.A. Air pollution and childhood respiratory health: exposure to sulfate and ozone in 10 Canadian rural communities. Environ. Res. 66(2):1994;125-142.
188. Stockstill B.L., Chang L.Y., Menache M.G., Mellick P.W., Mercer R.R., Crapo J.D. Bronchiolarized metaplasia and interstitial fibrosis in rat lungs chronically exposed to high ambient levels of ozone. Toxicol. Appl. Pharmacol. 134(2):1995;251-263.
189. Sun J., Koto H., Chung K.F. Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int. Arch. Allergy Immunol. 112(2):1997;191-195.
190. Takahashi G.W., Andrews D.F., Lilly M.B., Singer J.W., Alderson M.R. Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood. 81(2):1993;357-364.
191. Tepper J.S., Costa D.L., Fitzgerald S., Doerfler D.L., Bromberg P.A. Role of tachykinins in ozone-induced acute lung injury in guinea pigs. J. Appl. Physiol. 75(3):1993;1404-1411.
192. Tepper J.S., Costa D.L., Lehmann J.R., Weber M.F.et al. Unattenuated structural and biochemical alterations in the rat lung during functional adaption to ozone. Am. Rev. Respir. Dis. 140:1989;493-501.
193. Tyler W.S., Tyler N.K., Last J.A., Gillespie M.J., Barstow T.J. Comparison of daily and seasonal exposures of young monkeys to ozone. Toxicology. 50(2):1988;131-144.
194. van der Wal W.A., van Bree L., Marra M., Rombout P.J. Attenuation of acute lung injury by ozone inhalation - the effect of low level pre-exposure. Toxicol. Lett. 72(1-3):1994;291-298.
195. Weinmann, G.G., Liu, M.C., Proud, D., Weidenbach-Gerbase, M., Hubbard, W., Frank, R., 1995a. Ozone exposure in humans: inflammatory, small and peripheral airway responses. Am. J. Respir. Crit. Care Med. 152 (4 Pt 1), 1175-1182.
196. Weinmann G.G., Weidenbach-Gerbase M., Foster W.M, Zacur H., Frank R. Evidence for ozone-induced small-airway dysfunction: lack of menstrual-cycle and gender effects. Am. J. Respir. Crit. Care Med. 152(3):1995b;988-996.
197. Weller B.L., Crapo J.D., Slot J., Posthuma G., Plopper C.G., Pinkerton K.E. Site- and cell-specific alteration of lung copper/zinc and manganese superoxide dismutases by chronic ozone exposure. Am. J. Respir. Cell Mol. Biol. 17(5):1997;552-560.
198. Widdicombe J. Airway and alveolar permeability and surface liquid thickness: theory. Am. J. Physiol. 82:1997;3-12.
199. Willis R.J., Kratzing C.C. Ascorbate acid in rat lung. Biochem. Biophys. Res. Commun. 59:1974;1250-1253.
200. Winterbourn C.C. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen-peroxide-chloride, and similarity of the oxidant hypochlorate. Biochem. Biophys. Acta. 840:1985;204-210.
201. Witting, L.A., 1980. Vitamin E and lipid antioxidants in free radical-initiated reactions. In: Free Radicals in Biology. Academic Press, New York, pp. 295-319.
202. WHO, 1987. World Health Organisation Regional Office for Europe, Air Quality Guidelines for Europe, vol. 23. WHO Regional Publications, Copenhagen, Denmark, pp. 315-326.
203. Ying R.L., Gross K.B., Terzo T.S., Eschenbacher W.L. Indomethacin does not inhibit the ozone-induced increase in bronchial responsiveness in human subjects. Am. Rev. Respir. Dis. 142(4):1990;817-821.
204. Yost B.L., Gleich G.J., Fryer A.D. Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein. J. Appl. Physiol. 87(4):1999;1272-1278.
205. Young W.A., Shaw D.B., Bates D.V. Effect of low concentrations of ozone on pulmonary function in man. J. Appl. Physiol. 19:1964;765-768.